0 Syst Biol 2010, 59:307–321 PubMedCrossRef Authors’ contributio

0. Syst Biol 2010, 59:307–321.PubMedCrossRef Authors’ contributions SP carried out the molecular genetic studies, participated

in the data acquisition and performed all analyses and drafted the manuscript. CL and LC participated in the data acquisition. RAG was involved in project conception and critical revision of the manuscript. PG and DB coordinated the study, participated in its design, in the data acquisition and drafted the manuscript. All authors read and approved the final manuscript.”
“Background Antibiotic abuse is, in part, JNK inhibitor responsible for the dramatic increase in the resistance of pathogens to traditional antibiotics [1]. Superbugs, such as MRSA and NDM-1, frequently and seriously threaten public safety [2, 3]. Consequently, the need to develop new classes of antibiotics with novel mechanisms of action AC220 clinical trial against drug-resistant pathogens is becoming very urgent. Enzybiotics [4–8] and antimicrobial peptides (AMPs)[9] have attracted much attention as potential substitutes for conventional antibiotics. In the present manuscript, enzybiotics

are referred to as bacterial BIX 1294 in vitro cell wall-degrading enzymes, including lysins, bacteriocins, autolysins, and lysozymes. The most important characteristics of enzybiotics are their novel mechanisms of antibacterial action and capacity to kill antibiotic-resistant bacteria [10]. Another significant feature of certain enzybiotics is their low probability of developing bacterial

resistance [11]. Compared with AMPs, enzybiotics are large, heat-labile, and narrow-spectrum types of antimicrobial proteins. Consequently, enzybiotics are not always suitable antimicrobial agents. Despite this, certain enzybiotics have been well characterized and widely used. Lysostaphin [12–15] and lysozymes [16–18] are the most studied enzybiotics in regards to their clinical or food applications. Furthermore, despite their apparent limitations in medicine, their potency against multi-drug-resistant pathogens should not be ignored. Therefore, an enzybiotic specific database that not only mobilizes research on enzybiotics, but also makes it more efficient and convenient, needs to be constructed. Over the past decade, many databases have been developed for AMPs. These databases, including Resveratrol APD [19, 20], ANTIMIC [21], CAMP [22], BACTIBASE [23, 24], PhytAMP [25], PenBase [26], Defensins [27], CyBase [28], and peptaibols Peptaibol [29], contain AMP sequences from diverse origins or specific families and accordingly have accelerated and stimulated research on AMPs. Conversely, the majority of the sequenced enzybiotics are stored in the manually annotated UniProt/Swiss-Prot [30] database or scattered in the scientific literature. As a result, it is difficult to find information on enzybiotics for recent users.

The calculated repeating unit with a length of about 2 0 nm was o

The calculated repeating unit with a length of about 2.0 nm was obtained. The obtained experimental value was in range of 2.0~2.1 nm, which was in good accordance with the calculation result. In addition, for the xerogels of TC14-Lu from DMF, with the decrement of alkyl substituent chains, the weaker intermolecular hydrophobic force between the alkyl chains of the neighboring molecules will not enable present gelators to orderly assemble as in the case of TC18-Lu and shows a shorter layer distance and more disorderly stacking unit. For the case of TC12-Lu, no gel can be prepared due to the shortest alkyl

substituent chains, as shown in Figure 9b. Meanwhile, it should be www.selleckchem.com/products/BKM-120.html noted that this phenomenon is similar to the results of recent reports [49, 50]. Therein, the substituent groups in azobenzene residue or benzimidazole/benzothiazole imide derivatives can have a profound effect upon the gelation abilities and the as-formed nanostructures of the studied click here compounds. For the

present system, the experimental results demonstrated again that the alkyl substituent chains had played a very important role in regulating the assembly modes and nanostructures in these organogels. Now the ECL properties generated by the present xerogels of these luminol derivatives in the presence of hydrogen peroxide are under investigation to display the relationship between the molecular structures, as-formed nanostructures, and ECL sensors. Figure 9 Schematic pictures of assembly modes. (a) TC18-Lu in organogels and (b) TC12-Lu selleck inhibitor in solution. Conclusions Some luminol imide derivatives with different alkyl

substituent chains have been synthesized. Their gelation behaviors in various organic solvents can be regulated by changing the length Thymidine kinase and number of alkyl substituent chains. The experimental data demonstrated that the length of alkyl substituent chains linked to a benzene ring in these imide derivatives can have a profound effect upon the gelation abilities of these studied compounds. Longer alkyl chains in molecular skeletons in the present gelators are favorable for the gelation of organic solvents. Morphological studies revealed that the gelator molecules self-assemble into different aggregates from dot, flower, belt, rod, and lamella, to wrinkle with change of solvents. Spectral studies indicated that there existed different H-bond formations and hydrophobic force, depending on the alkyl substituent chains in molecular skeletons. The present research work affords a new useful exploration for the design and development of new versatile low molecular mass organogelators and soft matter for ECL biosensors with luminol functional groups. Authors’ information TJ and QZ are associate professors. QH is an MD student. DX is a professor. FG is a professor and the dean of the School of Environmental and Chemical Engineering. JZ is a laboratory assistant in Yanshan University.

9%~79 8%[3] Che Xiaoming et al achieved similar outcomes by colo

9%~79.8%[3]. Che Xiaoming et al achieved similar outcomes by colony selection with the learn more use of limited dilution, and harvested about 82% cells that have the proliferation capacity[2]. We obtained highly purified BTSCs by their method. As is known to all, EGF and bFGF, as powerful promoters of cell division, are essential key components in stem cell culture medium, and enable stem cells to proliferate continuously. Through MTT experiment,

we have found that ATRA alone can promote the proliferation of BTSCs, but the promoting effect is weaker than EGF+bFGF, and there is no obvious synergistic or antagonistic effect between ATRA and EGF+bFGF. Previous researches have showed that ATRA can inhibit the proliferation of ordinary glioma cells cultured in serum-containing medium, promoting apoptosis of the glioma cells. We have observed that BTSCs in the control group grew as suspended spheres when cultured in the medium without serum and growth

factors. Similar to the control group, BTSCs in the ATRA group were not adherent, but the formed spheres were larger and the proliferation was more rapid, indicating that ATRA did not induce the Tariquidar differentiation of the suspended BTSCs, but promote the proliferation of BTSCs. The reason may be as mentioned below. In the serum-free medium, BTSCs can achieve continuous self renewal and proliferation through symmetric division, retaining the stem cell characteristics; and in the serum-containing Isotretinoin medium, because of the influence of certain substance in the serum, BTSCs can retain their existence through asymmetric division, and produce a great number of comparatively

mature progeny cells, which differentiate into ordinary tumor cells ultimately, so there is only a small percentage of BTSCs in the whole cell population. The PF-573228 cost targets of ATRA’s effect of differentiation induction are cells in the process of differentiation. For BTSCs in the stem cell state, ATRA has a promoting effect on their proliferation. So ATRA exerts opposite effects on BTSCs at different stages of differentiation, the mechanism of which needs further clarification. Clinical trials of differentiation of brain glioma cells induced by ATRA showed that the differentiation effect of ATRA alone was weak, with insignificant curative efficacy[8, 9]. We speculate that the application of ATRA alone can induce the differentiation and apoptosis of most ordinary glioma cells, but promote the proliferation of a minority of BTSCs that does not experience differentiation, that is to say, the “”seeds”" resulting in the formation, development and relapse of tumors do not decrease but increase, which may be exactly the major reason for the poor therapeutic effect. Research of Singh et al revealed that only CD133 positive cells had the stem cell characteristics of self-renewal, unlimited proliferation and multilineage parent differentiation[3]. These days, CD133 has been recognized as the marker to isolate and identify BTSCs.

thermophilus for SGII (Panel B) and SGI (Panel C) spacers In pan

thermophilus for SGII (Panel B) and SGI (Panel C) spacers. In panels B and C, each box represents a spacer in a CRISPR locus in the CRISPR Database, and colored boxes represent NVP-BGJ398 cost spacers that also were present in this study. White boxes represent spacers that were not identified in this study. In each subpanel, the colored LY2874455 manufacturer boxes from the top locus represent spacers that were matched by skin-derived spacers, and the bottom box represents spacers that were matched by saliva-derived spacers. To determine whether skin-derived CRISPR spacers

matched viruses present in the saliva, we sequenced the viromes present in each of our subjects’ saliva Selleckchem Geneticin on Day 1 and Week 8. Similar to our previous studies [14], the proportion of CRISPR spacers matching

virome reads was relatively low. When examining the pooled reads from all subjects, we found that between 0.0% and 1.0% of the CRISPR spacers in each subject matched virome reads for SGI spacers and SGII spacers (Additional file 2: Figure S7). When we tested the skin- and saliva-derived spacers against a larger database of salivary viromes from a cohort 21 human subjects [10], we found that a high number of salivary- and skin-derived spacers matched salivary virome reads (range from 14 to 60% for SGII spacers and 10 to 24% for SGI spacers). The proportion PDK4 of spacers matching salivary viruses was significantly (p ≤ 0.002) higher for saliva-derived spacers than

for skin-derived spacers for Subjects #3 and #4 for SGII spacers, but not Subjects #1 and #2. There also were a significantly higher proportion of SGI saliva-derived spacers that matched salivary viruses in Subjects #2 and #3, but not Subjects #1 and #4 (Figure 8). Figure 8 Percentage of SGI (Panel A) and SGII (Panel B) CRISPR spacers matching virome reads from the saliva of 21 human subjects [10]. The Y-axis shows the mean percentage of the CRISPR spacers from all time points combined that matched virome reads from the cohort of 21 subjects. The X-axis represents the saliva- and skin-derived spacers for each subject. Standard error bars are represented above each bar, and the p-value is demonstrated above each error bar. Subjects 1 through 4 are shown consecutively from left to right on the X-axis. We also tested whether there were matches to spacers found in previously sequences metagenomes recovered from the human oral cavity [39], the gastrointestinal tract [40], and human skin [41]. We found that a significantly higher percentage of SGII (3-4%) and SGI (4-5%) spacer sequences were found in oral metagenomes than the 1-2% of SGII and SGI found in the gut and the <1% found on the skin (p < 0.02) (Additional file 2: Figure S8, Panels A and B).

The honey crop, with its constant nectar flow, high osmotic press

The honey crop, with its constant nectar flow, high osmotic pressure, and presence of microorganisms introduced by foraging is the ideal environment for these systems

to be activated. These systems in these conditions rely on specific gene expressions in different cell processes, such as extra-cellular proteins and peptides, to deal with these harsh environmental conditions [19]. In general, LAB can produce great amounts of cell surface and extra-cellular proteins such as bacteriocins, molecular chaperones, enzymes, lipoproteins, and surface layer proteins [6, 20] that are involved in varying cell processes. Surface layer or extracellular proteins are essential DNA Damage inhibitor for niche Selleckchem FRAX597 protection, and their survival forms part of the proteome known as the “secretome” [21]. From

our previous research we have seen that these symbiotic LAB species possess antimicrobial properties against bee pathogens and other microorganisms introduced by nectar foraging and they work together synergistically as a defense system [15, 18]. In this work we investigate whether this activity could be attributable to any secreted proteins. To that end, we identify extra-cellular proteins from each Lactobacillus and Bifidobacterium spp. from the honey crop separately under microbial stress in order to understand their ecological roles as antimicrobial barriers against incoming threats and their roles in honey production. Results The honey crop Lactobacillus Fhon13N, Biut2N, Hma8N, Bin4N, Hon2N, Hma11N, Hma2N, Bma5N, and Lacobacillus kunkeei Fhon2N have genome sizes ranging from 1.5 to 2.2 Mbps, and the number of predicted proteins ranges from 1330 to 2078 (Table  1). The fraction of predicted proteins in these strains with known Anlotinib cell line function is on average 71%, the fraction without known function but similar to other known proteins is on average of 26%, and proteins without known function or similarity are on average 4%. The honey crop Bifidobacterium Bin2N, Bin7N,

Hma3N, and Bifidobacterium coryneforme Bma6N have genome sizes ranging from 1.7 to 2.2 Mbps, and the number of predicted proteins ranges from 1386 to 1836 (Table  1). The fraction of predicted proteins in Bin2N, Bin7N, Hma3N, and B. Ureohydrolase coryneforme Bma6N with known function is on average 69%, without known function but similar to other known proteins is on average 26%, and proteins without known function or similarity are on average 5%. Further genomic data and analysis on these 13 LAB species will be covered in full detail in another paper. Table 1 Genomic characteristics of the 13 LAB symbionts from the honey crop   Genome size (Mb) Total ORFs ORFs – with assigned function (%) ORFs – without assigned function, with similarity (%) ORFs – no similarity or assigned function (%) Lactobacillus           Fhon13N 1.5 1 330 72 25 4 Fhon2N 1.6 1 504 73 24 3 Bin4N 1.

There may be small differences in the age- and sex-specific BMD i

There may be small differences in the age- and sex-specific BMD in different European countries as well as within countries. If so, these differences in BMD are relatively small and insufficient to account for selleck kinase inhibitor the observed differences in fracture rates (see below). Risk factors for fracture BMD Assessment of BMD has provided a crucial determinant of fracture risk, and many guidelines have used BMD thresholds to determine whether treatments should be recommended. Intervention thresholds

have ranged from T-scores of −3 SD to −1.5 SD depending on the clinical context, the country or health economic factors [1, 47–51]. The use of bone mass measurements for prognosis depends upon accuracy. Accuracy in this context is the ability of the measurement to predict fracture. In general, all densitometric selleck chemicals llc techniques have high specificity but low sensitivity which varies with the cutoff chosen to designate high risk. At the age of 50 years, for example, the proportion of women with osteoporosis who will fracture their hip, spine, forearm or proximal humerus in the next 10 years (i.e. positive predictive value) is approximately 45 %. Despite this, the overall detection rate for these

fractures (sensitivity) is low, Selleckchem LY3023414 and 96 % of fractures at the spine, hip, forearm or proximal humerus will occur in women without osteoporosis [52]. The low sensitivity is one of the reasons why widespread population-based screening with BMD is not widely recommended in women at the time selleck compound of the menopause [7]. Many cross-sectional and prospective population studies indicate that the risk for fracture increases by a factor of 1.5 to 3.0 for each standard deviation decrease in bone mineral density [31]. The ability of bone mineral density to predict fracture is comparable to the use of blood pressure to predict stroke and substantially better than serum cholesterol to predict myocardial infarction [7]. There are,

however, significant differences in the performance of different techniques at different skeletal sites. In addition, the performance depends on the type of fracture that one wishes to predict [31, 53]. For example, BMD assessments by DXA to predict hip fracture are more predictive when measurements are made at the hip rather than at the spine or forearm (Table 4). For the prediction of hip fracture, the gradient of risk provided by hip BMD in a meta-analysis is 2.6 [31]. In other words, the fracture risk increases 2.6-fold for each SD decrease in hip BMD. Thus, an individual with a Z-score of −3 at the hip would have a 2.63 or greater than 15-fold higher risk than an individual of the same age with a Z-score of 0. Where the intention is to predict any osteoporotic fracture, the commonly used techniques are comparable: The risk of fracture increases approximately 1.

We also used valid operationalisations to measure both concepts

We also used valid operationalisations to measure both concepts. In line with Probst (2003), we measured job insecurity as a ‘rich’ concept, including both cognitive job insecurity (i.e. perceived chance of job loss) and affective GDC0449 job insecurity (i.e. worry about job loss). We also focused on the combination of task demands and autonomy. This

gave us the opportunity to assess, within each contract type, the proportion of jobs with four theoretically relevant combinations of job characteristics, both positive and negative. Finally, we did not operationalise Karasek’s four job types by a rough division of autonomy and task demands (e.g. by means of a crude median split), but based our division on substantive grounds, that is, on absolute answer category labels, which more accurately correspond to the categorisation of ‘low’ versus ‘high’ control and demands. Future research Some recommendations for future research are the following. First, the current study showed much diversity in the quality of working life and job insecurity among temporary workers. Therefore, future research should search for specific risk groups for health and well-being problems by focusing on temporary workers, especially agency workers, with a low quality

of working life and high job insecurity. Secondly, find more on-call work proved to be a distinct form of temporary employment. Therefore, future research should separate on-call work from other forms of temporary employment and should investigate the profile(s) of these workers more extensively. Thirdly, the quality of working life and job insecurity acted somewhat differently in explaining health and work-related attitudinal differences between contract types. Thus, future research should distinguish between these two factors in the context of employment contracts, most CH5183284 mw notably in relation to employability and turnover intention. Finally, longitudinal research is needed to test whether employment contracts and health and work-related attitudes affect each other reciprocally. To this

aim, we must study different career paths, not only in terms of contract transitions and transitions between employment and unemployment (e.g., Kompier et al. 2009; P. Virtanen et al. 2005), check details but also regarding quality of working life and job insecurity. In this way, we can discover which type of work leads to health and attitudinal problems (and eventually to unemployment), and which type of work serves as a stepping stone to healthier work. Conflict of interest The authors declare that they have no conflict of interest. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

and earlier studies on TNKS1

and earlier studies on TNKS1 function during mitosis. Huang et al. found that small molecule drug XAV939 didn’t cause mitotic arrest in DLD-1 colon cancer cells, neither RNAi-TNKS1 do. The results were in sharp contrast with other studies [28,

29, 31]. In the present study we also found that the three NB cell lines, when treated with XAV939, have a prolonged S phase followed by a G2/M cell cycle arrest compared to untreated cells. This discrepancy may be related to different types of GSI-IX cancer and need to be further investigated. Recently it has been shown that XAV939 inhibits DLD-1 colony formation in an axin-dependent manner [14]. Axin is a concentration-limiting factor in the β-catenin degradation complex and may function more generally as a signal ‘integrator’ in modulating Wnt pathway activity. In our studies, XAV939 as well as shRNA for TNKS1 inhibited SH-SY5Y colony formation in vitro (Figure 2). In conclusion, the present data and previous studies indicate that small molecule click here inhibitors XAV939 could inhibit the proliferation and colony formation of SH-SY5Y cells by inhibiting TNKS1 might in part through Wnt/β-catenin signaling. But the results are required to be validated in vivo to get a better understanding of the mechanisms involved and the potential check details role of XAV939 in NB treatment. Moreover, TNKS1 is a protein that participates in both telomere regulation and Wnt/β-catenin signaling, which are essential factors

for tumor remedy and recurrence. However, the relationship between the telomere regulation and Wnt/β-catenin signaling need to be further explored. The research will pave the way for NB treatment used by TNKS1 inhibitors. Conclusions In sum, we have shown that inhibition of TNKS1 by XAV939 or RNAi method inhibits the proliferation and induces apoptosis of NB cell lines. One of the related mechanisms may be the inhibiting of Wnt/β-catenin signaling. But more experiments should be carried out to clarify the exact mechanisms. This effect would be expected to promote small 3-mercaptopyruvate sulfurtransferase molecule targeted therapy in patients with malignant

NB. Acknowledgments The study was supported by National Natural Science Foundation of China (30772215). The authors would like to thank Professor Yuhua Chen and Xining Pang of Departnzent of Developmental Biology in China Medical University, and people who help us. References 1. Maris JM, Matthay KK: Molecular biology of neuroblastoma. J Clin Oncol 1999, 17:2264–2279.PubMed 2. Maris JM, Hogarty MD, Bagatell R, Cohn SL: Neuroblastoma. Lancet 2007, 369:2106–2120.PubMedCrossRef 3. Sharp SE, Gelfand MJ, Shulkin BL: Pediatrics: diagnosis of neuroblastoma. Semin Nucl Med 2011, 41:345–353.PubMedCrossRef 4. Bilir A, Erguven M, Yazihan N, Aktas E, Oktem G, Sabanci A: Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y. J Neurooncol 2010, 100:385–395.PubMedCrossRef 5.

It is minimally

invasive and does not require intracardia

It is minimally

invasive and does not require intracardiac catheterization. It can give beat-by-beat monitoring of cardiac output, and can provide accurate information on volume status [74]. Vasopressor agents Vasopressor agents should be administered early in patients with severe sepsis or septic shock of abdominal origin to restore organ perfusion. Their early use may prevent excessive fluid resuscitation. Vasopressor drugs maintain adequate blood pressure and Selleckchem ARRY-438162 preserve perfusion pressure thus optimizing blood flow in various organs. Norepinephrine is now the first-line vasopressor agent used to correct hypotension in the event of septic shock [11]. Norepinephrine Selleck SB202190 is more efficacious than dopamine and may be more effective for reversing hypotension in patients with septic shock. In MEK inhibitor drugs 1993, Martin et al. showed in a prospective, double-blind, randomized trial that norepinephrine was more effective and reliable than dopamine to reverse the abnormalities of hyper dynamic septic shock [75]. The Surviving Sepsis Campaign guidelines favour norepinephrine [11] and there have been studies since the 2008 update to bolster this preference. De Backer et al. investigated this question in a meta-analysis, focusing only

on those patients with septic shock and again showed that dopamine was associated with greater mortality than norepinephrine [76]. It is well known that dopamine may cause more tachycardia and may be more arrhythmogenic than norepinephrine [77], and as an alternative vasopressor agent to norepinephrine, it should be used only in patients with low risk Ribonucleotide reductase of tachyarrhythmias and absolute or relative bradycardia. Epinephrine is a potent α-adrenergic and β-adrenergic agent that increases mean arterial pressure by increasing both, cardiac index and peripheral vascular tone. There are concerns regarding the use of epinephrine in septic patients due to its potential to decrease regional blood flow, particularly in the splanchnic circulation, and elevations in serum lactate. However, no trials have shown that epinephrine results in worse outcomes,

so it may be used as an alternative to norepinephrine [78, 79]. Vasopressin is a peptide hormone synthesized in the hypothalamus and subsequently transported to the pituitary gland where it is stored. It is released in response to decreased blood volume, decreased intravascular volume, and increased plasma osmolality. Vasopressin constricts vascular smooth muscle by directly activating V1 receptors and simultaneously increasing the vasculature’s responsiveness to catecholamines [80]. Vasopressin (up to 0.03 U/min) can be added to norepinephrine with the intent of raising MAP to target or decreasing the norepinephrine dose [11]. Inotropic agents Dobutamine is frequently used to treat septic shock patients as an inotropic agent increasing cardiac output, stroke index, and oxygen delivery (Do2).

This may be due to that the temperature of the Ni sphere on the t

This may be due to that the temperature of the Ni sphere on the top of the growing CdS nanoneedle decreases to satisfy the VS growth conditions

as the CdS nanoneedle grow to a certain length. The growth of the small CdS nanoneedle on the top of the main nanoneedle is called the secondary growth mode as shown in Figure 7. Figure 7 Growth model for the secondary growth of CdS nanoneedle. Conclusions In conclusion, the substrate this website temperature and the pulse laser energy affect the growth mode of the CdS nanoneedles, but the influenced factors are interacted. The formation of the molten catalyst spheres is confirmed to be the key to the nucleation of the CdS nanoneedles by observing the morphologies

of the Ni-catalyst thin films annealed at different substrate temperatures. Under the certain conditions, changing the substrate temperature or the pulse laser energy may cause the changes of the growth modes of the CdS nanoneedles. In our experiments, under the same laser energy, the growth mode of the CdS nanoneedles is VS at a substrate temperature of 400°C, but it turns into VLS at a substrate temperature of 450°C. Also, altering the pulse laser energy from 50 to 80 mJ may also change the growth modes of the CdS nanoneedles from VLS to VS. Besides, the secondary growth of the smaller CdS nanoneedles is found on the tops of the main CdS nanoneedles. In secondary growth mode, the main CdS nanoneedles grow in VLS mode with catalysts leading, and the secondary selleck inhibitor CdS nanoneedles grow in VS mode without catalysts leading due to the decrease of the temperature of the Ni spheres on the tops of the main nanoneedles. Acknowledgements This work is supported by the National Basic Research Program of China (973 Program, Grant No. 2012CB934303) and National Natural Science Foundation of China. References 1. Kumar ND, Joshi MP, Friend CS, Prasad PN, Burzynski R: Organic–inorganic heterojunction light

emitting diodes based HSP90 on poly (p-phenylene vinylene)/cadmium sulfide thin films. Appl Phys Lett 1997,71(10):1388–1390.BGB324 clinical trial CrossRef 2. Smyntyna V, Golovanov V, Kaciulis S, Mattogno G, Righini G: Influence of chemical composition on sensitivity and signal reproducibility of CdS sensors of oxygen. Sensor Actuat B-Chem 1995,25(1):628–630.CrossRef 3. Birkmire RW, Eser E: Polycrystalline thin film solar cells: present status and future potential. Annu Rev Mater Sci 1997, 27:625–653.CrossRef 4. Zhao JL, Bardecker JA, Munro AM, Liu MS, Niu YH, Ding IK, Luo JD, Chen BQ, Jen AKY, Ginger DS: Efficient CdSe/CdS quantum dot light-emitting diodes using a thermally polymerized hole transport layer. Nano Lett 2006,6(3):463–475.CrossRef 5.